Primary amyloidosis associated with multiple myeloma. Predictors of successful therapy
- 1 March 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 80 (3) , 413-418
- https://doi.org/10.1016/0002-9343(86)90715-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.British Journal of Haematology, 1983
- Amyloid Production in Human Myeloma Stem-Cell Culture, with Morphologic Evidence of Amyloid Secretion by Associated MacrophagesNew England Journal of Medicine, 1982
- Primary Systemic AmyloidosisArchives of internal medicine (1960), 1982
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980
- Primary systemic amyloidosis: comparison of melphalan and prednisone versus placeboBlood, 1978
- RESOLUTION OF AMYLOIDOSIS AND PLASMA-CELL DYSCRASIA WITH COMBINATION CHEMOTHERAPYThe Lancet, 1978
- The Successful Treatment of Primary Amyloidosis with Intermittent ChemotherapyAustralian and New Zealand Journal of Medicine, 1978
- Resolution of Primary Amyloidosis During ChemotherapyAnnals of Internal Medicine, 1975
- TREATMENT OF "PRIMARY" RENAL AMYLOIDOSIS WITH MELPHALANThe Lancet, 1972
- Amyloid Fibril Proteins: Proof of Homology with Immunoglobulin Light Chains by Sequence AnalysesScience, 1971